Virtual Medicinal Product (VMP)
-
Nandrolone 50mg/1ml solution for injection ampoules
Name Details
Current Name
Nandrolone 50mg/1ml solution for injection ampoules
|
Start Date
08-06-2004
|
End Date
|
Previous Name
Nandrolone 50mg/ml injection 1ml ampoules
|
Start Date
13-02-2003
|
End Date
07-06-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Intramuscular
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular-deep
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A14AB01
BNF |
Current BNF
06040300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040300
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36029311000001101 |
29-10-2018 |
|
350380000 |
13-02-2003 |
28-10-2018 |
VMP Ingredients
Name
Nandrolone decanoate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Nandrolone
-
VMP
(Current) Nandrolone 50mg/1ml solution for inj...
Virtual Medicinal Product Pack (VMPP) Information